Regeneron Pharmaceuticals | REGN - Equity Capital And Reserves


Regeneron Pharmaceuticals reported $33.5B in Equity Capital and Reserves for its fiscal quarter ending in September of 2026.





Equity Capital And Reserves Change Date
AbbVie USD -5.94B 721M Jun/2026
Agenus USD -199.08M 22.15M Jun/2026
Agios Pharmaceuticals USD 1.03B 83.09M Jun/2026
Alnylam Pharmaceuticals USD 3.6B 2.25B Sep/2026
Amgen USD 11.69B 2.5B Jun/2026
Astellas Pharma JPY 1.94T 113.64B Jun/2026
AstraZeneca USD 51.73B 1.43B Sep/2026
Biogen USD 19.04B 194.3M Sep/2026
BioMarin Pharmaceutical USD 6.32B 109.58M Jun/2026
Bristol-Myers Squibb USD 23.4B 1.08B Sep/2026
Eli Lilly USD 40.27B 6.39B Sep/2026
Gilead Sciences USD 13.04B 1.3B Sep/2026
GlaxoSmithKline GBP 18.75B 1.11B Sep/2026
Incyte USD 5.64B 701.49M Sep/2026
Ionis Pharmaceuticals USD 439.74M 51.68M Jun/2026
J&J USD 81.53B 3.44B Sep/2026
Kyowa Hakko Kirin JPY 908.54B 7.62B Sep/2026
Merck USD 41.93B 3.94B Jun/2026
Moderna USD 6.76B 647M Jun/2026
Neurocrine Biosciences USD 3.69B 286.2M Jun/2026
Novartis USD 41.95B 3.02B Jun/2026
Novartis USD 37.56B 1.36B Sep/2026
Pfizer USD 85.19B 4.91B Jun/2026
Puma Biotechnology USD 115.27M 10.55M Sep/2025
Regeneron Pharmaceuticals USD 33.5B 1.79B Sep/2026
Roche Holding CHF 32.69B 1.11B Jun/2026
Sanofi EUR 69.57B 3.58B Jun/2026
Sarepta Therapeutics USD 1.53B 22.7M Jun/2026
Teva Pharmaceutical Industries USD 7.75B 475M Jun/2026
Ultragenyx Pharmaceutical USD -291M 55M Jun/2026
United Therapeutics USD 6.4B 499.2M Jun/2026
Vertex Pharmaceuticals USD 20.25B 886M Jun/2026